相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficient Palladium-Assisted One-Pot Deprotection of (Acetamidomethyl)Cysteine Following Native Chemical Ligation and/or Desulfurization To Expedite Chemical Protein Synthesis
Suman Kumar Maity et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Development of Solid-Phase Site-Specific Conjugation and Its Application toward Generation of Dual Labeled Antibody and Fab Drug Conjugates
Sujiet Puthenveetil et al.
BIOCONJUGATE CHEMISTRY (2016)
Intracellular Released Payload Influences Potency and Bystander-Killing Effects of Antibody-Drug Conjugates in Preclinical Models
Fu Li et al.
CANCER RESEARCH (2016)
New developments for antibody-drug conjugate-based therapeutic approaches
Bart E. C. G. de Goeij et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Recent advances in the construction of antibody-drug conjugates (vol 8, pg 114, 2016)
Vijay Chudasama et al.
NATURE CHEMISTRY (2016)
Dual modification of biomolecules
Antoine Maruani et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2016)
Antibody Drug Conjugates for Cancer Therapy
Paul Polakis
PHARMACOLOGICAL REVIEWS (2016)
Site-Specific Antibody-Drug Conjugates: The Nexus of Biciorthogonal Chemistry, Protein Engineering, and Drug Development
Paresh Agarwal et al.
BIOCONJUGATE CHEMISTRY (2015)
Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution
Nicholas McGranahan et al.
CANCER CELL (2015)
A Novel Anti-CD22 Anthracycline-Based Antibody-Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs
Shang-Fan Yu et al.
CLINICAL CANCER RESEARCH (2015)
Tumor Cells Chronically Treated with a Trastuzumab-Maytansinoid Antibody-Drug Conjugate Develop Varied Resistance Mechanisms but Respond to Alternate Treatments
Frank Loganzo et al.
MOLECULAR CANCER THERAPEUTICS (2015)
CD30 Downregulation, MMAE Resistance, and MDR1 Upregulation Are All Associated with Resistance to Brentuximab Vedotin
Robert Chen et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Reducing hydrophobicity of homogeneous antibody-drug conjugates improves pharmacokinetics and therapeutic index
Robert P. Lyon et al.
NATURE BIOTECHNOLOGY (2015)
A plug-and-play approach to antibody-based therapeutics via a chemoselective dual click strategy
Antoine Maruani et al.
NATURE COMMUNICATIONS (2015)
Antibody- Drug Conjugates: An Emerging Concept in Cancer Therapy
Ravi V. J. Chari et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Brentuximab Vedotin in the Front-Line Treatment of Patients With CD30+ Peripheral T-Cell Lymphomas: Results of a Phase I Study
Michelle A. Fanale et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Ado-trastuzumab Emtansine (T-DM1): An Antibody-Drug Conjugate (ADC) for HER2-Positive Breast Cancer
John M. Lambert et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates
Robert P. Lyon et al.
NATURE BIOTECHNOLOGY (2014)
Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study
Anas Younes et al.
LANCET ONCOLOGY (2013)
Tumour heterogeneity and cancer cell plasticity
Corbin E. Meacham et al.
NATURE (2013)
Labeling Thiols on Proteins, Living Cells, and Tissues with Enhanced Emission Induced by FRET
Yue Yuan et al.
SCIENTIFIC REPORTS (2013)
The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
Peter D. Senter et al.
NATURE BIOTECHNOLOGY (2012)
Antibody-Maytansinoid Conjugates Designed to Bypass Multidrug Resistance
Yelena V. Kovtun et al.
CANCER RESEARCH (2010)
Intracellular Activation of SGN-35, a Potent Anti-CD30 Antibody-Drug Conjugate
Nicole M. Okeley et al.
CLINICAL CANCER RESEARCH (2010)
Functional genomics identifies ABCC3 as a mediator of taxane resistance in HER2-amplified breast cancer
Carol O'Brien et al.
CANCER RESEARCH (2008)
Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: Effects of linker technology on efficacy and toxicity
SO Doronina et al.
BIOCONJUGATE CHEMISTRY (2006)
分享论文
